Cargando…
Pharmacological Treatments for Congenital Myasthenic Syndromes Caused by COLQ Mutations
BACKGROUND: Congenital myasthenic syndromes (CMS) refer to a series of inherited disorders caused by defects in various proteins. Mutation in the collagen-like tail subunit of asymmetric acetylcholinesterase (COLQ) is the second-most common cause of CMS. However, data on pharmacological treatments a...
Autores principales: | Shao, Shuai, Shi, Guanzhong, Bi, Fang-Fang, Huang, Kun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472815/ https://www.ncbi.nlm.nih.gov/pubmed/36703579 http://dx.doi.org/10.2174/1570159X21666230126145652 |
Ejemplares similares
-
Two patients with congenital myasthenic syndrome caused by COLQ gene mutations and the consequent ColQ protein defect
por: Zhang, Qiting, et al.
Publicado: (2023) -
A COLQ Missense Mutation in Labrador Retrievers Having Congenital Myasthenic Syndrome
por: Rinz, Caitlin J., et al.
Publicado: (2014) -
Congenital myasthenic syndrome in Golden Retrievers is associated with a novel COLQ mutation
por: Tsai, Kate L., et al.
Publicado: (2019) -
A COLQ Missense Mutation in Sphynx and Devon Rex Cats with Congenital Myasthenic Syndrome
por: Abitbol, Marie, et al.
Publicado: (2015) -
COLQ-mutation congenital myasthenic syndrome in late adolescence: Case report and review of the literature()
por: Yin, Yatao, et al.
Publicado: (2023)